Inhibrx Biosciences (INBX) EPS (Diluted) (2023 - 2026)
Powered by 
Analysis
Inhibrx Biosciences (INBX) EPS (Diluted) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 0.15 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -0.06 |
| 10 | Inhibrx Biosciences | 1.92 Bn | 1.92 Bn | - | -2.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.34 |
| Dec 31, 2025 | -2.12 |
| Sep 30, 2025 | -2.28 |
| Jun 30, 2025 | -1.85 |
| Mar 31, 2025 | -2.80 |
| Dec 31, 2024 | -3.19 |
| Sep 30, 2024 | -2.84 |
| Jun 30, 2024 | 125.48 |
| Mar 31, 2024 | -5.77 |
| Dec 31, 2023 | -7.81 |
| Sep 30, 2023 | -4.39 |
| Jun 30, 2023 | -4.31 |